Pertussis toxin B-oligomer suppresses IL-6 induced HIV-1 and chemokine expression in chronically infected U1 cells via inhibition of activator protein 1

Journal of Immunology

Volumn 176, Issue 2, 2006, Pages 999-1006

  Rizzi, Chiara ^a   Crippa, Massimo P ^a   Jeeninga, Rienk E ^b   Berkhout, Ben ^b   Blasi, Francesco ^a,c,d   Poli, Guido ^a,c   Alfano, Massimo ^a,e  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

^e Dipartimento di Ricerca Biotecnologica   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; MONOCYTE CHEMOTACTIC PROTEIN 1; OLIGOMER; PERTUSSIS TOXIN; PERTUSSIS TOXIN B OLIGOMER; STAT3 PROTEIN; TRANSCRIPTION FACTOR AP 1; UNCLASSIFIED DRUG; UROKINASE RECEPTOR;

ARTICLE; BINDING SITE; CHRONIC DISEASE; COMPETITIVE INHIBITION; DNA BINDING; EUKARYOTIC CELL; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INFECTION; LIFE CYCLE; LONG TERMINAL REPEAT; MACROPHAGE ACTIVATION; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION; TRANSCRIPTION REGULATION; VIRUS REPLICATION;

EID: 30744471901     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.176.2.999     Document Type: Article

References (86)

1. Rappuoli, R. 1994. Pathogenicity mechanisms of Bordetella. Curr. Top. Microbiol. Immunol. 192: 319-336.
2. Rappuoli, R., and M. Pizza. 1991. Structure and evolutionary aspects of ADP-ribosylating toxins. In Sourcebook of Bacterial Toxins. J. Alouf and J. Freer, eds. Academic Press, London, pp. 1-20.
3. Alfano, M., H. Schmidtmayerova, C. A. Amella, T. Pushkarsky, and M. Bukrinsky. 1999. The B-oligomer of pertussis toxin deactivates CC chemokine receptor 5 and blocks entry of M-tropic HIV-1 strains. J. Exp. Med. 190: 597-605.
4. Garcia, J. G., P. Wang, F. Liu, M. B. Hershenson, T. Borbiev, and A. D. Verin. 2001. Pertussis toxin directly activates endothelial cell p42/p44 MAP kinases via a novel signaling pathway. Am. J. Physiol 280: C1233-C1241.
5. Li, H., and W. S. Wong. 2001. Pertussis toxin activates tyrosine kinase signaling cascade in myelomonocytic cells: a mechanism for cell adhesion. Biochem. Biophys. Res. Commun. 283: 1077-1082.
6. Wong, W. S., and P. M. Rosoff. 1996. Pharmacology of pertussis toxin B-oligomer. Can. J. Physiol. Pharmacol. 74: 559-564.
7. Kolb, J. P., E. Genot, E. Petit-Koskas, N. Paul-Eugene, and B. Dugas. 1990. Effect of bacterial toxins on human B cell activation. I. Mitogenic activity of pertussis toxin. Eur. J. Immunol. 20: 969-976.
8. Guntermann, C., B. J. Murphy, R. Zheng, A. Qureshi, P. A. Eagles, and K. E. Nye. 1999. Human immunodeficiency virus-1 infection requires pertussis toxin sensitive G-protein-coupled signalling and mediates cAMP downregulation. Biochem. Biophys. Res. Commun. 256: 429-435.
9. Alfano, M., G. Vallanti, P. Biswas, C. Bovolenta, E. Vicenzi, B. Mantelli, T. Pushkarsky, R. Rappuoli, A. Lazzarin, M. Bukrinsky, et al. 2001. The binding subunit of pertussis toxin inhibits HIV replication in human macrophages and virus expression in chronically infected promonocytic U1 cells. J. Immunol. 166: 1863-1870.
10. Alfano, M., T. Pushkarsky, G. Poli, and M. Bukrinsky. 2000. The B-oligomer of pertussis toxin inhibits human immunodeficiency virus type 1 replication at multiple stages. J. Virol. 74: 8767-8770.
11. Chowdhury, I. H., Y. Koyanagi, O. Hazeki, M. Ui, and N. Yamamoto. 1994. Pertussis toxin inhibits induction of human immunodeficiency virus type 1 in infected monocytes. Virology 203: 378-383.
12. Poli, G., P. Bressler, A. Kinter, E. Duh, W. C. Timmer, A. Rabson, J. S. Justement, S. Stanley, and A. S. Fauci. 1990. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor α by transcriptional and posttranscriptional mechanisms. J. Exp. Med. 172: 151-158.
13. Weissman, D., G. Poli, and A. S. Fauci. 1994. Interleukin 10 blocks HIV replication in macrophages by inhibiting the autocrine loop of tumor necrosis factor α and interleukin 6 induction of virus. AIDS Res. Hum. Retroviruses 10: 1199-1206.
14. + T cells using a combination of cytokines. J. Exp. Med. 188: 83-91.
15. Biswas, P., F. Delfanti, S. Bernasconi, M. Mengozzi, M. Cota, N. Polentarutti, A. Mantovani, A. Lazzarin, S. Sozzani, and G. Poli. 1998. Interleukin-6 induces monocyte chemotactic protein-1 in peripheral blood mononuclear cells and in the U937 cell line. Blood 91: 258-265.
16. Lane, B. R., K. Lore, P. J. Bock, J. Andersson, M. J. Coffey, R. M. Strieter, and D.M. Markovitz. 2001. Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy. J. Virol. 75: 8195-8202.
17. + T cells of HIV-infected individuals is regulated by a balance between the viral suppressive effects of endogenous β-chemokines and the viral inductive effects of other endogenous cytokines. Proc. Natl. Acad. Sci. USA 93: 14076-14081.
18. Goletti, D., A. L. Kinter, P. Biswas, S. M. Bende, G. Poli, and A. S. Fauci. 1995. Effect of cellular differentiation on cytokine-induced expression of human immunodeficiency virus in chronically infected promonocytic cells: dissociation of cellular differentiation and viral expression. J. Virol. 69: 2540-2546.
19. Shapiro, L., K. A. Heidenreich, M. K. Meintzer, and C. A. Dinarello. 1998. Role of p38 mitogen-activated protein kinase in HIV type 1 production in vitro. Proc. Natl. Acad. Sci. USA 95: 7422-7426.
20. Biswas, P., G. Poli, A. L. Kinter, J. S. Justement, S. K. Stanley, W. J. Maury, P. Bressler, J. M. Orenstein, and A. S. Fauci. 1992. Interferon γ induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions to intracytoplasmic vacuoles in phorbol myristate acetate-differentiated U1 cells. J. Exp. Med. 176: 739-750.
21. Poli, G., A. Kinter, J. S. Justement, J. H. Kehrl, P. Bressler, S. Stanley, and A. S. Fauci. 1990. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA 87: 782-785.
22. Cannon, P., S. H. Kim, C. Ulich, and S. Kim. 1994. Analysis of Tat function in human immunodeficiency virus type 1-infected low-level-expression cell lines U1 and ACH-2. J. Virol. 68: 1993-1997.
23. Pomerantz, R. J., D. Trono, M. D. Feinberg, and D. Daltimore. 1990. Cells non-productively infected with HIV-1 exhibit an aberrant pattern of viral RNA expression: a molecular model for latency. Cell 61: 1271-1276.
24. Kim, S. Y., R. Byrn, J. Groopman, and D. Baltimore. 1989. Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression. J. Virol. 63: 3708-3713.
25. Emiliani, S., C. Van Lint, W. Fischle, P. Paras, Jr., M. Ott, J. Brady, and E. Verdin. 1996. A point mutation in the HIV-1 Tat responsive element is associated with postintegration latency. Proc. Natl. Acad. Sci. USA 93: 6377-6381.
26. Rizzi, C., M. Alfano, A. Dugatti, M. Camozzi, G. Poli, and M. Rusnati. 2004. Inhibition of intra- and extra-cellular Tat function and HIV expression by pertussis toxin D-oligomer. Eur. J. Immunol. 34: 530-536.
27. Folks, T. M., J. Justement, A. Kinter, S. Schnittman, J. Orenstein, G. Poli, and A. S. Fauci. 1988. Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate. J. Immunol. 140: 1117-1122.
28. Alfano, M., and G. Poli. 2001. Cytokine and chemokine based control of hiv infection and replication. Curr. Pharm. Des. 7: 993-1013.
29. Alfano, M., and G. Poli. 2002. The cytokine network in HIV infection. Curr. Mol. Med. 2: 677-689.
30. Siliciano, J. D., and R. F. Siliciano. 2000. Latency and viral persistence in HIV-1 infection. J. Clin. Invest. 106: 823-825.
31. Blankson, J. N., D. Persaud, and R. F. Siliciano. 2002. The challenge of viral reservoirs in HIV-1 infection. Annu. Rev. Med. 53: 557-593.
32. Cullen, D. R. 1998. HIV-1 auxiliary proteins: making connections in a dying cell. Cell 93: 685-692.
33. Pereira, L. A., K. Dentley, A. Peeters, M. J. Churchill, and N. J. Deacon. 2000. A compilation of cellular transcription factor interactions with the HIV-1 LTR promoter. Nucleic Acids Res. 28: 663-668.
34. Chen, P., E. Flory, A. Avots, B. W. Jordan, F. Kirchhoff, S. Ludwig, and U. R. Rapp. 2000. Transactivation of naturally occurring HIV-1 long terminal repeats by the JNK signaling pathway: the most frequent naturally occurring length polymorphism sequence introduces a novel binding site for AP-1 factors. J. Biol. Chem. 275: 20382-20390.
35. Alfano, M., N. Sidenius, B. Panzeri, F. Blasi, and G. Poli. 2002. Urokinase-urokinase receptor interaction mediates an inhibitory signal for HIV-1 replication. Proc. Natl. Acad. Sci. USA 99: 8862-8867.
36. Zack, J. A., A. J. Cann, J. P. Lugo, and I. S. Chen. 1988. HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation. Science 240: 1026-1029.
37. Csoma, E., A. Bacsi, X. Liu, J. Szabo, P. Ebbesen, Z. Beck, J. Konya, I. Andirko, E. Nagy, and F. D. Toth. 2002. Human herpesvirus 6 variant a infects human term syncytiotrophoblasts in vitro and induces replication of human immunodeficiency virus type 1 in dually infected cells. J. Med. Virol. 67: 67-87.
38. Kinter, A. L., P. Biswas, M. Alfano, J. S. Justement, B. Mantelli, C. Rizzi, A. R. Gatti, E. Vicenzi, P. Bressler, and G. Poli. 2001. Interleukin-6 and glucocorticoids synergistically induce human immunodeficiency virus type-1 expression in chronically infected u1 cells by a long terminal repeat independent posttranscriptional mechanism. Mol. Med. 7: 668-678.
39. Bovolenta, C., S. Gasperini, and M. A. Cassatella. 1996. Granulocyte colony-stimulating factor induces the binding of STAT1 and STAT3 to the IFNγ response region within the promoter of the FcγRI/CD64 gene in human neutrophils. FEBS Lett. 386: 239-242.
40. Bovolenta, C., L. Camorali, A. L. Lorini, G. Vallanti, S. Ghezzi, G. Tambussi, A. Lazzarin, and G. Poli. 1999. In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors ying-yang-1 and leader binding protein-1/late simian virus 40 factor. J. Immunol. 163: 6892-6897.
41. Folks, T. M., J. Justement, A. Kinter, C. A. Dinarello, and A. S. Fauci. 1987. Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line. Science 238: 800-802.
42. Pomerantz, R. J., M. B. Feinberg, D. Trono, and D. Baltimore. 1990. Lipopolysaccharide is a potent monocyte/macrophage-specific stimulator of human immunodeficiency virus type 1 expression. J. Exp, Med. 172: 253-261.
43. Goletti, D., A. L. Kinter, E. C. Hardy, G. Poli, and A. S. Fauci. 1996. Modulation of endogenous TL-1β and IL-1 receptor antagonist results in opposing effects on HIV expression in chronically infected monocytic cells. J. Immunol. 156: 3501-3508.
44. Montano, M. A., C. P. Nixon, T. Ndung'u, H. Bussmann, V. A. Novitsky, D. Dickman, and M. Essex. 2000. Elevated tumor necrosis factor-α activation of human immunodeficiency virus type 1 subtype C in southern Africa is associated with an NF-κB enhancer gain-of-function. J. Infect. Dis. 181: 76-81.
45. Ihle, J. N. 1996. STATs: signal transducers and activators of transcription. Cell 84: 331-334.
46. Davis, R. J. 1993. The mitogen-activated protein kinase signal transduction pathway. J. Biol. Chem. 268: 14553-14556.
47. Seger, R., and E. G. Krebs. 1995. The MAPK signaling cascade. FASEB J. 9: 726-735.
48. Van Lint, C., A. Burny, and E. Verdin. 1991. The intragenic enhancer of human immunodeficiency virus type 1 contains functional AP-1 binding sites. J. Virol. 65: 7066-7072.
49. Yang, X., Y. Chen, and D. Gabuzda. 1999. ERK MAP kinase links cytokine signals to activation of latent HIV-1 infection by stimulating a cooperative interaction of AP-1 and NF-κB. J. Biol. Chem. 274: 27981-27988.
50. Benasciutti, E., G. Pages, O. Kenzior, W. Folk, F. Blasi, and M. P. Crippa. 2004. MAPK and JNK transduction pathways can phosphorylate Sp1 to activate the uPA minimal promoter element and endogenous gene transcription. Blood 104: 256-262.
51. Ibanez-Tallon, I., C. Ferrai, E. Longobardi, I. Facetti, F. Blasi, and M. P. Crippa. 2002. Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells. Blood 100: 3325-3332.
52. Jeeninga, R. E., M. Hoogenkamp, M. Armand-Ugon, M. de Baar, K. Verhoef, and B. Berkhout. 2000. Functional differences between the long terminal repeat transcriptional promoters of human immunodeficiency virus type 1 subtypes A through G. J. Virol. 74: 3740-3751.
53. Roebuck, K. A. 1999. Regulation of interleukin-8 gene expression. J. Interferon Cytokine Res. 19: 429-438.
54. Roebuck, K. A., L. R. Carpenter, V. Lakshminarayanan, S. M. Page, J. N. Moy, and L. L. Thomas. 1999. Stimulus-specific regulation of chemokine expression involves differential activation of the redox-responsive transcription factors AP-1 and NF-κB. J. Leukocyte Biol. 65: 291-298.
55. + T cells: role of signal transduction. Proc. Natl. Acad. Sci. USA 95: 11880-11885.
56. Mengozzi, M., C. De Filippi, P. Transidico, P. Biswas, M. Cota, S. Ghezzi, E. Vicenzi, A. Mantovani, S. Sozzani, and G. Poli. 1999. Human immunodeficiency virus replication induces monocyte chemotactic protein-1 in human macrophages and U937 promonocytic cells. Blood 93: 1851-1857.
57. Vicenzi, E., M. Alfano, S. Ghezzi, A. Gatti, F. Veglia, A. Lazzarin, S. Sozzani, A. Mantovani, and G. Poli. 2000. Divergent regulation of HIV-1 replication in PBMC of infected individuals by CC chemokines: suppression by RANTES, MIP-1α, and MCP-3, and enhancement by MCP-1. J. Leukocyte Biol. 68: 405-412.
58. Cinque, P., L. Vago, M. Mengozzi, V. Torri, D. Ceresa, E. Vicenzi, P. Transidico, A. Vagani, S. Sozzani, A. Mantovani, et al. 1998. Elevated cerebrospinal fluid levels of monocyte chemotactic protein-1 correlate with HIV-1 encephalitis and local viral replication. AIDS 12: 1327-1332.
59. Iordanskiy, S., T. Iordanskaya, V. Quivy, C. Van Lint, and M. Bukrinsky. 2002. B-oligomer of pertussis toxin inhibits HIV-1 LTR-driven transcription through suppression of NF-κB p65 subunit activity. Virology 302: 195-206.
60. Rabbi, M. F., M. Saifuddin, D. S. Gu, M. F. Kagnoff, and K. A. Roebuck. 1997. U5 region of the human immunodeficiency virus type 1 long terminal repeat contains TRE-like cAMP-responsive elements that bind both AP-1 and CREB/ ATF proteins. Virology 233: 235-245.
61. + T cells. J. Biol. Chem. 270: 19364-19369.
62. Briant, L., V. Robert-Hebmann, V. Sivan, A. Brunet, J. Pouyssegur, and C. Devaux. 1998. Involvement of extracellular signal-regulated kinase module in HIV-mediated CD4 signals controlling activation of nuclear factor-κB and AP-1 transcription factors. J. Immunol. 160: 1875-1885.
63. Gibellini, D., M. C. Re, A. Bassini, L. Guidotti, L. Catani, M. La Placa, and G. Zauli. 1999. HIV-1 gp120 induces the activation of both c-fos and c-jun immediate-early genes in HEL megakaryocytic cells. Br. J. Haematol. 104: 81-86.
64. + T cells. Br. J. Haematol. 112: 663-670.
65. Gonzalez, E., C. Punzon, M. Gonzalez, and M. Fresno. 2001. HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter. J. Immunol. 166: 4560-4569.
66. Varin, A., S. K. Manna, V. Quivy, A. Z. Decrion, C. Van Lint, G. Herbein, and B. B. Aggarwal. 2003. Exogenous Nef protein activates NF-κB, AP-1, and c-Jun N-terminal kinase and stimulates HIV transcription in promonocytic cells: role in AIDS pathogenesis. J. Biol. Chem. 278: 2219-2227.
67. De Cesare, D., D. Vallone, A. Caracciolo, P. Sassone-Corsi, C. Nerlov, and P. Verde. 1995. Heterodimerization of c-Jun with ATF-2 and c-Fos is required for positive and negative regulation of the human urokinase enhancer. Oncogene 11: 365-376.
68. Canonne-Hergaux, F., D. Aunis, and E. Schaeffer. 1995. Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells. J. Virol. 69: 6634-6642.
69. Krebs, F. C., D. Mehrens, S. Pomeroy, M. M. Goodenow, and B. Wigdahl. 1998. Human immunodeficiency virus type 1 long terminal repeat quasispecies differ in basal transcription and nuclear factor recruitment in human glial cells and lymphocytes. J. Biomed. Sci. 5: 31-44.
70. Schwartz, C., F. Canonne-Hergaux, D. Aunis, and E. Schaeffer. 1997. Characterization of nuclear proteins that bind to the regulatory TGATTGGC motif in the human immunodeficiency virus type 1 long terminal repeat. Nucleic Acids Res. 25: 1177-1184.
71. Leppa, S., M. Eriksson, R. Saffrich, W. Ansorge, and D. Bohmann. 2001. Complex functions of AP-1 transcription factors in differentiation and survival of PC12 cells. Mol. Cell. Biol. 21: 4369-4378.
72. Herdegen, T., P. Skene, and M. Bahr. 1997. The c-Jun transcription factor-bipotential mediator of neuronal death, survival and regeneration. Trends Neurosci. 20: 227-231.
73. Herdegen, T., and J. D. Leah. 1998. Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28: 370-490.
74. Wagner, S., and M. R. Green. 1994. DNA-binding domains: targets for viral and cellular regulators. Curr. Opin. Cell. Biol. 6: 410-414.
75. Hai, T., and T. Curran. 1991. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc. Natl. Acad. Sci. USA 88: 3720-3724.
76. Benbrook, D. M., and N. C. Jones. 1994. Different binding specificities and transactivation of variant CRE's by CREB complexes. Nucleic Acids Res. 22: 1463-1469.
77. Centlivre, M., P. Sommer, M. Michel, R. H. Fang, S. Gofflo, J. Valladeau, N. Schmitt, F. Thierry, B. Hurtrel, S. Wain-Hobson, et al. 2005. HIV-1 clade promoters strongly influence spatial and temporal dynamics of viral replication in vivo. J. Clin. Invest. 115: 348-358.
78. Lemieux, A. M., M. E. Pare, B. Audet, E. Legault, S. Lefort, N. Boucher, S. Landry, T. van Opijnen, B. Berkhout, M. H. Naghavi, et al. 2004. T-cell activation leads to poor activation of the HIV-1 clade E long terminal repeat and weak association of nuclear factor-κB and NFAT with its enhancer region. J. Biol. Chem. 279: 52949-52960.
79. Naghavi, M. H., S. Schwartz, A. Sonnerborg, and A. Vahlne. 1999. Long terminal repeat promoter/enhancer activity of different subtypes of HIV type 1. AIDS Res. Hum. Retroviruses 15: 1293-1303.
80. van Opijnen, T., R. E. Jeeninga, M. C. Boerlijst, G. P. Pollakis, V. Zetterberg, M. Salminen, and B. Berkhout. 2004. Human immunodeficiency virus type 1 subtypes have a distinct long terminal repeat that determines the replication rate in a host-cell-specific manner. J. Virol. 78: 3675-3683.
81. Wetzel, M. A., A. D. Steele, E. E. Henderson, and T. J. Rogers. 2002. The effect of X4 and R5 HIV-1 on C, C-C, and C-X-C chemokines during the early stages of infection in human PBMCs. Virology 292: 6-15.
82. Bernasconi, S., P. Cinque, G. Peri, S. Sozzani, A. Crociati, W. Torri, E. Vicenzi, L. Vago, A. Lazzarin, G. Poli, et al. 1996. Selective elevation of monocyte chemotactic protein-1 in the cerebrospinal fluid of AIDS patients with cytomegalovirus encephalitis. J. Infect. Dis. 174: 1098-1101.
83. Di Tommaso, A., M. Bartalini, S. Peppoloni, A. Podda, R. Rappuoli, and M. T. De Magistris. 1997. Acellular pertussis vaccines containing genetically detoxified pertussis toxin induce long-lasting humoral and cellular responses in adults. Vaccine 15: 1218-1224.
84. Zocchi, M. R., P. Contini, M. Alfano, and A. Poggi. 2005. Pertussis Toxin (PTX) B subunit and the nontoxic PTX mutant PT9K/129G inhibit Tat-induced TGF-β production by NK cells and TGF-β-mediated NK cell apoptosis. J. Immunol. 174: 6054-6061.
85. Alfano, M., J. C. Grivel, S. Ghezzi, D. Corti, M. Trimarchi, G. Poli, and L. Margolis. 2005. Pertussis toxin B-oligomer dissociates T cell activation and HIV replication in CD4 T cells released from infected lymphoid tissue. AIDS 19: 1007-1014.
86. Lapenta, C., M. Spada, S. M. Santini, S. Racca, F. Dorigatti, G. Poli, F. Belardelli, and M. Alfano. 2005. Pertussis toxin B-oligomer inhibits HIV infection and replication in hu-PBL-SCID mice. Int. Immunol. 17: 469-475.